Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Gardner

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|August 29, 2018
CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndromeCintia Massillo, Guillermo Nicolás Dalton, Juliana Porretti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2014
Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed miceCristian P Moiola, Paola De Luca, Florencia Zalazar, et al.
International Journal of Cancer|March 15, 2018
CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome diseaseJuliana Porretti, Guillermo N Dalton, Cintia Massillo, et al.
Cellular and Molecular Life Sciences : CMLS|February 21, 2007
Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenograftsYongping You, Xiaozeng Geng, Peng Zhao, et al.
Molecular Pharmacology|June 17, 2008
Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridolYun Ge, Jung S Byun, Paola De Luca, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2009
Identification of new Rel/NFkappaB regulatory networks by focused genome location analysisAdriana De Siervi, Paola De Luca, Cristian Moiola, et al.
Oncotarget|March 3, 2016
CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAsPaola De Luca, Guillermo N Dalton, Georgina D Scalise, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 15, 2020
Whole-Exome Profiling of NSCLC Among African AmericansRony F Arauz, Jung S Byun, Mayank Tandon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2004
Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitmentJames L Smith, Wendy J Freebern, Irene Collins, et al.
The American Journal of Pathology|January 12, 2008
Transcriptional networks inferred from molecular signatures of breast cancerRon Tongbai, Gila Idelman, Silje H Nordgard, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|August 29, 2018
CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndromeCintia Massillo, Guillermo Nicolás Dalton, Juliana Porretti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2014
Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed miceCristian P Moiola, Paola De Luca, Florencia Zalazar, et al.
International Journal of Cancer|March 15, 2018
CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome diseaseJuliana Porretti, Guillermo N Dalton, Cintia Massillo, et al.
Cellular and Molecular Life Sciences : CMLS|February 21, 2007
Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenograftsYongping You, Xiaozeng Geng, Peng Zhao, et al.
Molecular Pharmacology|June 17, 2008
Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridolYun Ge, Jung S Byun, Paola De Luca, et al.
Cell Cycle (Georgetown, Tex.)|June 9, 2009
Identification of new Rel/NFkappaB regulatory networks by focused genome location analysisAdriana De Siervi, Paola De Luca, Cristian Moiola, et al.
Oncotarget|March 3, 2016
CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAsPaola De Luca, Guillermo N Dalton, Georgina D Scalise, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 15, 2020
Whole-Exome Profiling of NSCLC Among African AmericansRony F Arauz, Jung S Byun, Mayank Tandon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2004
Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitmentJames L Smith, Wendy J Freebern, Irene Collins, et al.
The American Journal of Pathology|January 12, 2008
Transcriptional networks inferred from molecular signatures of breast cancerRon Tongbai, Gila Idelman, Silje H Nordgard, et al.
Pageof 9